L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies. (2020)

First Author: Sendama W
Attributed to:  Optimising Innate Host Defence to Combat Antimicrobial Resistance funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.csbj.2020.11.054

PubMed Identifier: 33312454

Publication URI: http://europepmc.org/abstract/MED/33312454

Type: Journal Article/Review

Volume: 18

Parent Publication: Computational and structural biotechnology journal

ISSN: 2001-0370